In the past 10 years, Avivia has been involved in the pharmaceutical application of mesoporous silica in a diverse range of functionalities in pharmaceutical formulations, ranging from its “simple” application as a processing aid, to the more advanced applications in solubility, stability and bioavailability improvement and most recently the construction of stable ternary amorphous systems. To test the formulations, specific characterization methods needed to be developed to gain a deeper understanding as to why it does or does not work under certain conditions. Several case studies illustrate how this approach can be applied to polymer based systems.
Avivia and Grace Silica GmbH have jointly presented their work during the JPAG symposium – Ensuring amorphous product quality: what are the challenges? The event took place on the 7th of December in London at the Royal Society of Chemistry.
December 19, 2017
M-building – Novio Tech Campus
6534 AT Nijmegen, The Netherlands
Email info [at] avivia.nl
Phone - Reception +31 (0)6-1968-6732